Procter & Gamble Company (The) (NYSE:PG – Get Free Report) CAO Matthew Janzaruk sold 725 shares of the stock in a transaction dated Thursday, October 30th. The stock was sold at an average price of $149.57, for a total transaction of $108,438.25. Following the sale, the chief accounting officer owned 979 shares of the company’s stock, valued at $146,429.03. This trade represents a 42.55% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link.
Procter & Gamble Trading Up 0.5%
NYSE PG opened at $149.56 on Friday. The stock has a market capitalization of $349.47 billion, a P/E ratio of 21.83, a P/E/G ratio of 3.87 and a beta of 0.36. Procter & Gamble Company has a 52-week low of $146.96 and a 52-week high of $180.43. The firm has a 50-day moving average price of $154.04 and a 200 day moving average price of $158.03. The company has a quick ratio of 0.51, a current ratio of 0.71 and a debt-to-equity ratio of 0.46.
Procter & Gamble (NYSE:PG – Get Free Report) last posted its quarterly earnings results on Friday, October 24th. The company reported $1.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.09. The firm had revenue of $22.39 billion during the quarter, compared to analysts’ expectations of $22.23 billion. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The firm’s revenue for the quarter was up 3.0% on a year-over-year basis. During the same period in the prior year, the company posted $1.93 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Equities research analysts expect that Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Dividend Announcement
Analyst Upgrades and Downgrades
Several research analysts recently issued reports on PG shares. Barclays cut their price target on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a report on Wednesday, October 1st. Evercore ISI restated an “in-line” rating and set a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. BNP Paribas Exane lowered their target price on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research report on Tuesday, September 23rd. Wells Fargo & Company lowered their target price on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research report on Thursday, September 25th. Finally, BNP Paribas restated an “outperform” rating and set a $177.00 target price on shares of Procter & Gamble in a research report on Friday, August 15th. Twelve equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $171.53.
Read Our Latest Analysis on PG
Institutional Trading of Procter & Gamble
Several large investors have recently modified their holdings of the business. B & T Capital Management DBA Alpha Capital Management grew its position in shares of Procter & Gamble by 2.3% in the first quarter. B & T Capital Management DBA Alpha Capital Management now owns 2,795 shares of the company’s stock valued at $476,000 after purchasing an additional 63 shares during the last quarter. Private Management Group Inc. grew its position in shares of Procter & Gamble by 4.8% in the first quarter. Private Management Group Inc. now owns 1,384 shares of the company’s stock valued at $236,000 after purchasing an additional 64 shares during the last quarter. Lantz Financial LLC grew its position in shares of Procter & Gamble by 1.2% in the second quarter. Lantz Financial LLC now owns 5,237 shares of the company’s stock valued at $834,000 after purchasing an additional 64 shares during the last quarter. Orca Investment Management LLC grew its position in shares of Procter & Gamble by 2.0% in the second quarter. Orca Investment Management LLC now owns 3,238 shares of the company’s stock valued at $516,000 after purchasing an additional 64 shares during the last quarter. Finally, Detalus Advisors LLC grew its position in shares of Procter & Gamble by 0.8% in the first quarter. Detalus Advisors LLC now owns 7,918 shares of the company’s stock valued at $1,349,000 after purchasing an additional 65 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
- Five stocks we like better than Procter & Gamble
- 10 Best Airline Stocks to Buy
- Why Microsoft’s Post-Earnings Dip Is a Buy-the-Pause Moment
- What is a Secondary Public Offering? What Investors Need to Know
- NVIDIA’s Billion-Dollar Bet Puts Nokia Back in the Growth Game
- Growth Stocks: What They Are, Examples and How to Invest
- Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
